Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Pediatric Blood & Cancer|January 24, 2017
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acidUrsula Creutzig, Michael N Dworzak, Konrad Bochennek, et al.
Klinische Padiatrie|May 10, 2021
[Antibacterial Prophylaxis in Children and Adolescents Undergoing Therapy for Cancer - Statement of the Society of Pediatric Oncology and Hematology (GPOH) and of the German Society for Pediatric Infectious Diseases (DGPI) on Two Current International Guidelines]Thomas Lehrnbecher, Arne Simon, Hans-Jürgen Laws, et al.
Cancer Medicine|January 11, 2026
Association of Time to Antibiotics With Outcome in Pediatric Patients Receiving Chemotherapy for Cancer With Fever in Neutropenia-An International Individual Patient Data Meta-AnalysisAmelie L Salomon, Roland A Ammann, Catherine Aftandilian, et al.
Cancers|April 13, 2023
Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-TrialsLars Tramsen, Konrad Bochennek, Monika Sparber-Sauer, et al.
BMC Pediatrics|February 2, 2020
Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN): a protocol for a multicenter longitudinal prospective observational studyJulia Roick, Reinhard Berner, Toralf Bernig, et al.
Nature|May 7, 2025
Oncogene aberrations drive medulloblastoma progression, not initiationKonstantin Okonechnikov, Piyush Joshi, Verena Körber, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2019
Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experienceElke Pfaff, Ahmed El Damaty, Gnana Prakash Balasubramanian, et al.
The Lancet. Oncology|June 27, 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialSelim Corbacioglu, Holger Lode, Susanne Ellinger, et al.
Mycoses|June 14, 2025
Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and SwitzerlandDanila Seidel, Zoi Dorothea Pana, Daniel Ebrahimi-Fakhari, et al.
Pageof 5